Literature DB >> 22981667

Oral delivery of anticancer drugs III: formulation using drug delivery systems.

Silvia Mazzaferro1, Kawthar Bouchemal, Gilles Ponchel.   

Abstract

In the past few years, the growth of nanometric size drug delivery systems (DDS) has burst into challenging innovations enabling real progresses to achieve oral delivery of anticancer drugs. DDS, such as polymeric nanoparticles, micelles, dendrimers and lipid-based formulations enable physico-chemical properties of cytotoxic agents to be improved and oral bioavailability to be enhanced. In this review we highlight current DDS used for the oral delivery of anticancer drugs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22981667     DOI： 10.1016/j.drudis.2012.08.007

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


  6 in total

1.  Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.

Authors:  Xingwang Zhang; Tianpeng Zhang; Yali Lan; Baojian Wu; Zhihai Shi
Journal:  AAPS PharmSciTech       Date:  2015-07-18       Impact factor: 3.246

2.  Transport and delivery of interferon-α through epithelial tight junctions via pH-responsive poly(methacrylic acid-grafted-ethylene glycol) nanoparticles.

Authors:  Mary Caldorera-Moore; Julia E Vela Ramirez; Nicholas A Peppas
Journal:  J Drug Target       Date:  2019-03-01       Impact factor: 5.121

3.  Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives.

Authors:  Gabriela Garrastazu Pereira; Tristan Rawling; Michele Pozzoli; Curtis Pazderka; Yongjuan Chen; Colin R Dunstan; Michael Murray; Fabio Sonvico
Journal:  Nanomaterials (Basel)       Date:  2018-10-13       Impact factor: 5.076

Review 4.  The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs.

Authors:  Yuanyuan Wang; Chao Pi; Xianhu Feng; Yi Hou; Ling Zhao; Yumeng Wei
Journal:  Int J Nanomedicine       Date:  2020-08-24

Review 5.  Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.

Authors:  Changyi Chen; Jian-Ming Lü; Qizhi Yao
Journal:  Med Sci Monit       Date:  2016-07-17

6.  Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery.

Authors:  Mazhar Ali Raja; Shah Zeenat; Muhammad Arif; Chenguang Liu
Journal:  Int J Nanomedicine       Date:  2016-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.